Solventum Corp traded at $67.70 this Monday March 9th, decreasing $1.71 or 2.46 percent since the previous trading session. Looking back, over the last four weeks, Solventum Corp lost 15.86 percent. Over the last 12 months, its price fell by 12.80 percent. Looking ahead, we forecast Solventum Corp to be priced at 67.31 by the end of this quarter and at 61.40 in one year, according to Trading Economics global macro models projections and analysts expectations.
Solventum Corp. is a global healthcare company. Its segments include Medical Surgical, Dental Solutions, Health Information Systems, and Purification and Filtration. Medical Surgical is a provider of solutions including advanced wound care, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. Dental Solutions provides dental and orthodontic products include brackets, aligners, restorative cements, and bonding agents that span the life of the tooth, including products designed for preventative dental care, direct and indirect restoration, and broad orthodontic needs. Health Information Systems offers healthcare systems with software solutions, including computer-assisted physician documentation, direct-to-bill and coding automation, speech recognition, and data visualization platforms. Purification and Filtration is a provider of purification and filtration technologies including filters, purifiers, cartridges, and membranes.